These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 31901224)

  • 1. The significance of exosomes in the development and treatment of hepatocellular carcinoma.
    Li X; Li C; Zhang L; Wu M; Cao K; Jiang F; Chen D; Li N; Li W
    Mol Cancer; 2020 Jan; 19(1):1. PubMed ID: 31901224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes derived from HCC cells induce sorafenib resistance in hepatocellular carcinoma both in vivo and in vitro.
    Qu Z; Wu J; Wu J; Luo D; Jiang C; Ding Y
    J Exp Clin Cancer Res; 2016 Sep; 35(1):159. PubMed ID: 27716356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma.
    Yang N; Li S; Li G; Zhang S; Tang X; Ni S; Jian X; Xu C; Zhu J; Lu M
    Oncotarget; 2017 Jan; 8(2):3683-3695. PubMed ID: 27713136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer.
    Wang H; Lu Z; Zhao X
    J Hematol Oncol; 2019 Dec; 12(1):133. PubMed ID: 31815633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma.
    Hu F; Miao L; Zhao Y; Xiao YY; Xu Q
    Drug Des Devel Ther; 2015; 9():3625-33. PubMed ID: 26203228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal microRNAs as Biomarkers and Therapeutic Targets for Hepatocellular Carcinoma.
    Sorop A; Constantinescu D; Cojocaru F; Dinischiotu A; Cucu D; Dima SO
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomes in hepatocellular carcinoma microenvironment and their potential clinical application value.
    He R; Wang Z; Shi W; Yu L; Xia H; Huang Z; Liu S; Zhao X; Xu Y; Yam JWP; Cui Y
    Biomed Pharmacother; 2021 Jun; 138():111529. PubMed ID: 34311529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis.
    Li R; Wang Y; Zhang X; Feng M; Ma J; Li J; Yang X; Fang F; Xia Q; Zhang Z; Shang M; Jiang S
    Mol Cancer; 2019 Jan; 18(1):18. PubMed ID: 30704479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy.
    Han LL; Lv Y; Guo H; Ruan ZP; Nan KJ
    World J Gastroenterol; 2014 Aug; 20(30):10249-61. PubMed ID: 25132742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2.
    Wang G; Zhao W; Wang H; Qiu G; Jiang Z; Wei G; Li X
    Med Sci Monit; 2019 Sep; 25():7209-7217. PubMed ID: 31553714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological functions and clinical applications of exosomal non-coding RNAs in hepatocellular carcinoma.
    Li C; Xu X
    Cell Mol Life Sci; 2019 Nov; 76(21):4203-4219. PubMed ID: 31300868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal microRNAs in hepatocellular carcinoma, expanding research field.
    Zheng BH; Ni XJ; Liu HB
    World J Gastroenterol; 2024 May; 30(20):2618-2620. PubMed ID: 38855155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value.
    Cui Y; Xu HF; Liu MY; Xu YJ; He JC; Zhou Y; Cang SD
    World J Gastroenterol; 2019 Apr; 25(15):1890-1898. PubMed ID: 31057302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting therapy for hepatocellular carcinoma by delivering microRNAs as exosomal cargo.
    Suda T
    World J Gastroenterol; 2024 May; 30(17):2369-2370. PubMed ID: 38813056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Non-Coding RNAs as Mediators of Tumor Microenvironment and Liver Cancer Cell Communication.
    Lin YH; Wu MH; Yeh CT; Lin KH
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma-derived exosomes in organotropic metastasis, recurrence and early diagnosis application.
    Ge Y; Mu W; Ba Q; Li J; Jiang Y; Xia Q; Wang H
    Cancer Lett; 2020 May; 477():41-48. PubMed ID: 32112905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New possibilities of targeted therapy in the treatment of hepatocellular carcinoma with the help of molecular biology].
    Hagymási K; Tulassay Z
    Orv Hetil; 2010 Oct; 151(43):1763-8. PubMed ID: 20940115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Expression and Function of Circadian Rhythm Genes in Hepatocellular Carcinoma.
    Jiang Y; Shen X; Fasae MB; Zhi F; Chai L; Ou Y; Feng H; Liu S; Liu Y; Yang S
    Oxid Med Cell Longev; 2021; 2021():4044606. PubMed ID: 34697563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomes and Hepatocellular Carcinoma: From Bench to Bedside.
    Sasaki R; Kanda T; Yokosuka O; Kato N; Matsuoka S; Moriyama M
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30897788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of lncRNAs in hepatocellular carcinoma: opportunities as novel targets for pharmacological intervention.
    Zou H; Shao CX; Zhou QY; Zhu GQ; Shi KQ; Braddock M; Huang DS; Zheng MH
    Expert Rev Gastroenterol Hepatol; 2016; 10(3):331-40. PubMed ID: 26558504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.